TNF-α antagonists and immunization

Current Infectious Disease Reports

Volumn 13, Issue 3, 2011, Pages 243-247

  Visser, Leo G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

23 valent pneumococcal polysaccharide vaccine; Adalimumab; Antibody response; BCG vaccine; Certolizumab; Etanercept; Golimumab; Half life; Hepatitis A vaccine; Hepatitis B vaccine; Humanized monoclonal antibodies; Immunization; Infliximab; Influenza vaccine; Lymphotoxin ; Measles, mumps, and rubella vaccine; Methotrexate; Polysaccharide vaccine; Primary immune response; Rheumatoid arthritis; Secondary immune responses; TNF receptor; Tumor necrosis factor; Tumor necrosis factor antagonist; Vaccination; Yellow fever vaccine

Indexed keywords

ADALIMUMAB; BCG VACCINE; CERTOLIZUMAB PEGOL; DIPHTHERIA TOXOID; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; INFLUENZA VACCINE; ISONIAZID; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; METHOTREXATE; NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TYPHOID VACCINE; YELLOW FEVER VACCINE;

ABSENCE OF SIDE EFFECTS; ANKYLOSING SPONDYLITIS; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CROHN DISEASE; DISEASE EXACERBATION; DRUG ANTAGONISM; DRUG HALF LIFE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOSUPPRESSIVE TREATMENT; INTERFERON PRODUCTION; JUVENILE RHEUMATOID ARTHRITIS; LOW DRUG DOSE; PSORIASIS; PSORIATIC ARTHRITIS; REVACCINATION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; TRAVEL;

EID: 79956206269     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-011-0183-y     Document Type: Article

References (29)

1. BB Aggarwal 2003 Signalling pathways of the TNF superfamily: a double-edged sword Nat Rev Immunol 3 745 56 12949498 10.1038/nri1184 1:CAS:528:DC%2BD3sXmvVWmtb0%3D (Pubitemid 41070815)
2. M Croft 2009 The role of TNF superfamily members in T-cell function and diseases Nat Rev Immunol 9 271 85 19319144 10.1038/nri2526 1:CAS:528: DC%2BD1MXjsFCrsrk%3D
3. Murphy KM, Travers P, Walport M. Janeway's immunobiology. 7th ed. November 2007 page 383
4. ED Lobo RJ Hansen JP Balthasar 2004 Antibody pharmacokinetics and pharmacodynamics J Pharm Sci 93 2645 68 15389672 10.1002/jps.20178 1:CAS:528:DC%2BD2cXpvV2isLk%3D (Pubitemid 39506617)
5. D Tracey L Klareskog E Sasso, et al. 2008 Tumor necrosis factor antagonist mechanisms of action: a comprehensive review Pharmacol Ther 117 244 79 18155297 10.1016/j.pharmthera.2007.10.001 1:CAS:528:DC%2BD1cXhtV2it74%3D
6. J Harris J Keane 2010 How tumour necrosis factor blockers interfere with tuberculosis immunity Clin Exp Immunol 161 1 9 20491796 1:CAS:528: DC%2BC3cXps1entb0%3D
7. RS Wallis 2008 Tumour necrosis factor antagonists: structure, function, and tuberculosis risks Lancet Infect Dis 8 601 11 18922482 10.1016/S1473- 3099(08)70227-5 1:CAS:528:DC%2BD1cXht1Omsr%2FP This review elucidates why soluble TNFR and TNF monoclonal antibodies have a different effect on the granulomatous infections, such as tuberculosis
8. WFC Rigby 2007 Drug insight: different mechanisms of action of tumour necrosis factor antagonists-passive-aggressive behaviour? Nat Clin Pract Rheumatol 3 227 33 17396108 10.1038/ncprheum0438 1:CAS:528:DC%2BD2sXjs12rs7Y%3D (Pubitemid 46860407)
9. L Genestier R Paillot S Fournel, et al. 1998 Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells J Clin Invest 102 322 8 9664073 10.1172/JCI2676 1:CAS:528:DyaK1cXkslOkt7o%3D (Pubitemid 28335191)
10. AH Roukens LG Visser 2008 Yellow fever vaccine: past, present and future Expert Opin Biol Ther 8 1787 95 18847312 10.1517/14712598.8.11.1787 1:CAS:528:DC%2BD1cXht1artrbM
11. M Scheinberg LS Guedes-Barbosa C Mangueira, et al. 2010 Yellow fever revaccination during infliximab therapy Arthritis Care Res (Hoboken) 62 896 888 10.1002/acr.20045
12. H Badsha M Daher CJ Edwards 2010 Live polio vaccine exposure while receiving anti-TNF therapy for reactive arthritis Int J Rheum Dis 13 184 96 20536606 10.1111/j.1756-185X.2010.01466.x
13. E Toussirot D Wendling 2005 Bacillus calmette-guérin vaccination in a patient treated with infliximab J Rheumatol 32 2500 1 16331800 (Pubitemid 41780679)
14. S Borte UG Liebert M Borte, et al. 2009 Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept Rheumatol (Oxford) 48 144 8 10.1093/rheumatology/ken436 1:STN:280:DC%2BD1M%2FmvVWmug%3D%3D
15. O Elkayam D Caspi T Reitblatt, et al. 2004 The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis Semin Arthritis Rheum 33 4 283 8 14978666 10.1053/j.semarthrit.2003.10.003 1:CAS:528:DC%2BD2cXhtVOksL8%3D (Pubitemid 38280827)
16. PJ Mease CT Ritchlin RW Martin, et al. 2004 Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept J Rheumatol 31 1356 61 15229957 1:CAS:528:DC%2BD2cXmtlSlt70%3D (Pubitemid 38879202)
17. MC Kapetanovic T Saxne A Sjöholm, et al. 2006 Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis Rheumatol (Oxford) 45 106 11 10.1093/rheumatology/kei193 1:CAS:528: DC%2BD2MXhtlagtbjP (Pubitemid 43033885)
18. JL Kaine AJ Kivitz C Birbara, et al. 2007 Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab J Rheumatol 34 272 9 17304653 1:CAS:528:DC%2BD2sXjtFCnsbk%3D
19. S Visvanathan GF Keenan DG Baker, et al. 2007 Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone J Rheumatol 34 952 7 17444589 1:CAS:528:DC%2BD2sXmtV2rt7Y%3D (Pubitemid 46774837)
20. LBS Gelinck AE van der Bijl LG Visser, et al. 2008 Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody response to the 23-valen pneumococcal polysaccharide vaccine Vaccine 26 3528 33 18502006 10.1016/j.vaccine.2008.04.028 1:CAS:528:DC%2BD1cXnt1SmtLs%3D
21. I Fomin D Caspi V Levy, et al. 2006 Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers Ann Rheum Dis 65 191 4 16014674 10.1136/ard.2005.036434 1:CAS:528:DC%2BD28XhsFeitL0%3D (Pubitemid 43131992)
22. MC Kapetanovic T Saxne JA Nilsson, et al. 2007 Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients Rheumatol (Oxford) 46 608 11 10.1093/rheumatology/kel366 1:CAS:528:DC%2BD2sXjslOnt78%3D (Pubitemid 46523304)
23. P Mamula JE Markowitz DA Piccoli, et al. 2007 Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease Clin Gastroenterol Hepatol 5 851 6 17544875 10.1016/j.cgh.2007.02.035 (Pubitemid 47031059)
24. LB Gelinck AE van der Bijl WE Beyer, et al. 2008 The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination Ann Rheum Dis 67 713 176 17965123 10.1136/ard.2007.077552 1:CAS:528:DC%2BD1cXmt1akurY%3D (Pubitemid 351571939)
25. O Elkayam A Bashkin M Mandelboim, et al. 2010 The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis Semin Arthritis Rheum 39 442 7 19246078 10.1016/j.semarthrit.2008.12.002 1:CAS:528: DC%2BC3cXmsVaqtb8%3D
26. S Salemi A Picchianti-Diamanti V Germano, et al. 2010 Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity Clin Immunol 134 113 20 19846344 10.1016/j.clim.2009.09.014 1:CAS:528:DC%2BC3cXjslCmtw%3D%3D
27. E Farmaki F Kanakoudi-Tsakalidou V Spoulou, et al. 2010 The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis Vaccine 28 5109 13 20470802 10.1016/j.vaccine.2010.03.080 1:CAS:528:DC%2BC3cXovFeruro%3D
28. JF Rahier M Moutschen A Van Gompel, et al. 2010 Vaccinations in patients with immune-mediated inflammatory diseases Rheumatol (Oxford) 49 1815 27 10.1093/rheumatology/keq183 1:CAS:528:DC%2BC3cXhtFGhtb7N This article provides a very practical review on recurrent issues of vaccination in patients with autoimmune inflammatory disease
29. • van Assen S, Elkayam O, Agmon-Levin N, et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European league against rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev. 2010 Dec 20. [Epub ahead of print]. This article is a very comprehensive systematic review on infection risks and efficacy of vaccination in patients with rheumatic disease.